2-(4-Chloro-3-nitrophenyl)-1H-imidazo[4,5-b]phenazine

Catalog No. :
ACDGPR744
CAS No. :
303059-17-8
Molecular Formula :
C19H10ClN5O2
Molecular Weight :
375.77

IUPAC Name:2-(4-chloro-3-nitrophenyl)-1H-imidazo[4,5-b]phenazine

2-(4-Chloro-3-nitrophenyl)-1H-imidazo[4,5-b]phenazine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-(4-Chloro-3-nitrophenyl)-1H-imidazo[4,5-b]phenazine
IUPAC Name2-(4-chloro-3-nitrophenyl)-1H-imidazo[4,5-b]phenazine
MDL No.MFCD02674874
Molecular FormulaC19H10ClN5O2
Molecular Weight375.77
SMILESO=[N+]([O-])C1=CC(C2=NC3=CC4=NC5=CC=CC=C5N=C4C=C3N2)=CC=C1Cl
InChI KeyAHYBWBYWJSVTQT-UHFFFAOYSA-N
Synonym14-(4-chloro-3-nitrophenyl)-2,9,13,15-tetraazatetracyclo[8.7.0.0^{3,8}.0^{12,16}]heptadeca-1,3(8),4,6,9,11,13,16-octaene;1H-Imidazo[4,5-b]phenazine, 2-(4-chloro-3-nitrophenyl)-;2-(4-CHLORO-3-NITROPHENYL)-1H-IMIDAZO(4,5-B)PHENAZINE
CAS No.303059-17-8

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACDGPR744 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACKJGP890 route compound structure diagram
    ACKJGP890655-86-7 In Stock
  2. Plus
  3. ACOEWU095 route compound structure diagram
    ACOEWU09596-99-1 In Stock
  4. Then
  5. ACDGPR744 route product structure diagram
    ACDGPR744303059-17-8
Inquiry

2. ACDGPR744 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACZRQD591 route compound structure diagram
    ACZRQD591151169-67-4 In Stock
  4. Then
  5. ACDGPR744 route product structure diagram
    ACDGPR744303059-17-8
Inquiry

Comments (0)